Pediatric Brain Tumor Foundation
Working to eliminate the challenges
of childhood brain tumors
Please leave this field empty

Cure the kids! Give Now

font size AAA

Research News


Study Results: New PLGA Research Demonstrates the Power of Teamwork in Improving Outcomes for Kids with Brain Tumors


Pediatric Brain Tumor Foundation and Partners Announce Investment in Novel Immunotherapy Research at the Chad Carr Pediatric Brain Tumor Center at Michigan Medicine


NCI-COG Pediatric MATCH Study Finds More Targetable Genetic Changes than Expected


Entrectinib, Roche’s New Precision Medicine Therapy, Shows Promise for Treating Pediatric Brain Tumors


Study Results: Immunotherapy Drug Shows Promise for Adult Glioblastoma Patients When Treated Before Surgery


Pediatric Brain Tumor Foundation Responds to State of the Union and the Need for More Government Funding for Childhood Cancer Research


Pediatric Brain Tumor Foundation Joins Other Members of Brain Tumor Funders’ Collaborative in Announcing $3 Million in Research Grants


Study Results: Liquid Biopsy Blood Test Shows Promise for Detecting Genetic Changes in Pediatric Brain Tumors


New Study: Radiation-associated Cognitive Decline Prevented in First Animal Model of Glioma


Pediatric Brain Tumor Foundation and A Kids’ Brain Tumor Cure Join Forces to Change the Outcome for All Children with Brain Cancer


New “Multi-Omic” Research Projects Launched to Confront the Complexity of Glioblastoma and Pediatric Brain Tumor Treatment Development
This week, the National Cancer Institute (NCI), the U.S. government’s principal agency for cancer research, announced funding for new adult and pediatric brain cancer research projects. The funding, totaling $4 million, was driven by the leadership of the NCI and concerted advocacy efforts of the U.S. brain tumor community, led by the Eliminate Cancer Initiative (ECI), the National Brain Tumor Society (NBTS), and the Pediatric Brain Tumor Foundation (PBTF).


Christopher Brandle Joy of Life Foundation and PBTF Partner Again to Fund Cutting-Edge Medulloblastoma Research
The Pediatric Brain Tumor Foundation (PBTF) has received a $150,000 grant from the Christopher Brandle Joy of Life Foundation (CBJOLF) to fund medulloblastoma research at Massachusetts General Hospital.


Phase 1b Clinical Trial for Genetically Modified Poliovirus Therapy Enrolling Children and Teens at Duke University


Researchers and Pediatric Brain Tumor Nonprofits Gather in Portland for 2018 Translating Discoveries to Cure the Kids


St. Jude Study Reveals Chronic Health Conditions Are Most Prevalent in Survivors of Pediatric Central Nervous System Cancers
A study by St. Jude has revealed that the extent of chronic health conditions in adult childhood cancer survivors is significantly more substantial than those in the general public. The results of this extensive research can be used to better inform future clinical guidelines, research investigations and health services planning for childhood cancer survivors.


NCI-COG Pediatric MATCH Trial Opens for Enrollment
A long-awaited and first-of-its-kind precision medicine clinical trial in childhood cancer is now open for enrollment. NCI-COG Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) will explore the effectiveness of targeted therapies in children and adolescents with brain and other solid tumors.


Medulloblastoma Study Reveals New Subtypes of Malignant Childhood Brain Tumor
A new study published in Nature has uncovered a series of previously undiscovered medulloblastoma subtypes. The results of this latest research are expected to help advance new treatments for this highly malignant brain tumor that predominantly occurs in childhood.


Meet the Experts Brings Together Chicago Medical Community and Pediatric Brain Tumor Families to Learn and Network
To help answer families’ questions about childhood brain tumor treatments and the challenges that may follow, the Pediatric Brain Tumor Foundation’s Meet the Experts program brings together medical experts and parent experts across the country.


PBTF Grant Awardee to Run Neuro-Oncology Program at Rady Children’s Hospital
Rady Children’s Hospital - San Diego has named Dr. Robert Wechsler-Reya program director of the Joseph Clayes III Research Center for Neuro-Oncology and Genomics.


UC San Diego Bioengineers Developing Potential Blood Test for Early Cancer Detection
A new blood test being developed by bioengineers at the University of California San Diego could provide a way to diagnose cancer early on without invasive surgical procedures.